Skip to main content
. 2024 Apr 23;14(3):565–574. doi: 10.3233/JPD-230212

Table 3.

Correlation between IIEF, EF, QS-M and demographic and clinical variables

Variable IIFE EF QS-M
R p R p R p
Age (y) –0.120 >0.05 –0.202 >0.05 –0.117 >0.05
SEC 0.215 >0.05 0.143 >0.05 0.198 >0.05
Disease duration (y) –0.326 0.003 –0.262 0.018 –0.154 >0.05
H&Y –0.432 0.001 –0.340 0.001 –0.295 0.007
DDL (mg/day) –0.221 >0.05 –0.118 >0.05 –0.097 >0.05
DDAL (mg/day) –0.157 >0.05 –0.206 >0.05 –0.062 >0.05
DDS 0.081 >0.05 0.068 >0.05 0.021 >0.05
TMOCA 0.413 0.001 0.359 0.001 0.252 0.024
MDS-UPDRS I –0.413 0.001 –0.372 0.000 –0.328 0.002
MDS-UPDRS II –0.055 0.001 –0.478 0.000 –0.411 0.000
FSS –0.438 0.001 –0.320 0.003 –0.343 0.001
PDSS 0.444 0.001 0.379 0.001 0.333 0.002
DAS 0.101 >0.05 0.115 >0.05 0.283 0.023
BDI –0.385 0.001 –0.233 0.037 –0.290 0.008
RSES –0.38 0.001 –0.268 0.016 –0.297 0.007

IIEF, International Index of Erectile Function; EF, erectile function; QS-M, Sexual Quotient-Male; SEC, socio-economic condition; H&Y, Hoehn and Yahr Stage; DDL, daily dosage levodopa; DDAL, daily dosage agonist levodopa; DDS, Dopaminergic Dysregulation Syndrome; T-MoCA, Telephone-Montreal Cognitive Assessment; MDS-UPDRS, Movement Disorder Society–Unified Parkinson’s Disease Rating Scale; FSS, Fatigue Severity Scale; PDSS, Parkinson’s Disease Sleep Scale; DAS, Dyadic Adjustment Scale; BDI, Beck Depression Inventory; RSES, Rosemberg’s Self-esteem Scale.